跳至主要内容
临床试验/NCT00096317
NCT00096317已完成1 期

The Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Ixabepilone In Patients With Advanced Cancer

Montefiore Medical Center2 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2003年3月最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
29
试验地点
2
主要终点
Effect of ketoconazole on the pharmacokinetics of ixabepilone

研究概览

简要总结

RATIONALE: Drugs used in chemotherapy, such as ixabepilone and ketoconazole, work in different ways to stop tumor cells from dividing so they stop growing or die. Giving ixabepilone with ketoconazole may kill more tumor cells.

PURPOSE: This phase I/II trial is studying the side effects and best dose of giving ixabepilone together with ketoconazole and to see how well they work in treating patients with advanced solid tumors.

详细描述

OBJECTIVES:

Primary

  • Determine the effect of ketoconazole on the pharmacokinetics of ixabepilone in patients with advanced solid tumors.

Secondary

  • Determine the safety of ixabepilone when administered alone and in combination with ketoconazole in these patients.
  • Determine, preliminarily, the antitumor activity of this regimen in these patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Effect of ketoconazole on the pharmacokinetics of ixabepilone

次要结局

  • Safety of ixabepilone with and without ketoconazole
  • Antitumor activity

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验